Cysteine-reactive ligand discovery in proteomes

Patent metadata

Field	Value
Publication number	US-10782295-B2
Application number	US-201414911316-A
Country	US
Kind code	B2
Filing date	Aug 13, 2014
Priority date	Aug 13, 2013
Publication date	Sep 22, 2020
Grant date	Sep 22, 2020

Abstract

Cells produce electrophilic products with the potential to modify and affect the function of proteins. Chemoproteomic methods have provided a means to qualitatively inventory proteins targeted by endogenous electrophiles; however, ascertaining the potency and specificity of these reactions to identify the most sensitive sites in the proteome to electrophilic modification requires more quantitative methods. Here, we describe a competitive activity-based profiling method for quantifying the reactivity of electrophilic compounds against 1000+ cysteines in parallel in the human proteome. Using this approach, we identify a select set of proteins that constitute hot spots for modification by various lipid-derived electrophiles, including the oxidative stress product 4-hydroxnonenal (HNE). We show that one of these proteins, ZAK kinase, is labeled by HNE on a conserved, active site-proximal cysteine, resulting in enzyme inhibition to create a negative feedback mechanism that can suppress the activation of JNK pathways by oxidative stress.

First claim

What is claimed is:

1. A method of screening one or more selective modulators of a kinase protein target, comprising:
(a) contacting a first set of proteins of a mammalian cell with a lipid-derived electrophile, wherein the lipid-derived electrophile is cysteine-reactive, lipid-derived electrophile that is a Michael acceptor having an α,β-unsaturated carbonyl group to generate an alkylated set of proteins;
(b) contacting the alkylated set of proteins with an alkynylated iodoacetamide probe, followed by reaction with an azido compound comprising a first isotopic marker, to provide an isotopically-marked alkylated set of proteins, wherein the reaction with the azido compound is carried out using a copper- catalyzed azide-alkyne cycloaddition reaction;
(c) contacting the first set of proteins of a mammalian cell of step (a), not exposed to the lipid- derived electrophile, with an alkynylated iodoacetamide probe, followed by reaction with an azido compound comprising a second isotopic marker, to provide an isotopically-marked control set of proteins, wherein the reaction with the azido compound is carried out using a copper-catalyzed azide-alkyne cycloaddition reaction, and wherein the first isotopic marker and the second isotopic marker are isotopically-differentiated azide-biotin tags comprising a Tobacco Etch Virus (TEV) cleavage sequence;
(d) combining the isotopically-marked alkylated set of proteins and the isotopically-marked control set of proteins to provide a combined sample;
(e) quantifying reactivities of the isotopically-marked alkylated set of proteins and the isotopically-marked control set of proteins to identify a kinase protein target by comparing the abundance of the first isotopic marker and the abundance of the second isotopic marker for each protein of the combined sample, wherein the kinase protein target possess at least 5-fold or higher ratio of the second isotopic marker to the first isotopic marker among the proteins of the combined sample, and wherein the site of selective cysteine modification by a lipid-derived electrophile is at a non-active site;
(f) incubating the kinase protein target with a plurality of candidate compounds to detect a binding between a candidate compound and the kinase protein target; and
(g) identifying one or more selective modulators of the kinase protein target, wherein the lipid-derived electrophile and the alkynylated iodoacetamide probe each independently has a micromolar affinity to the isotopically-marked alkylated set of proteins of a mammalian cell and to the isotopically-marked control set of proteins of a control mammalian cell.

2. The method of claim 1 , wherein the first set of proteins includes two or more proteins.

3. The method of claim 1 , wherein the lipid-derived electrophile is a stress-induced electrophile.

4. The method of claim 1 , wherein the lipid-derived electrophile undergoes a Michael conjugate addition reaction with a cysteine residue of one or more proteins of the first set of proteins.

5. The method of claim 4 , wherein the lipid-derived electrophile is 4-hydroxynonenal (HNE) or 15-deoxy-Al 2,14-prostaglandin J2 (15d-PGJ2).

6. The method of claim 1 , wherein the one or more selective modulators of the kinase protein target is a reversible inhibitor of the kinase protein target.

Assignees

• Scripps Research Inst

Inventors

• Cravatt Benjamin
• Wang Chu
• Backus Keriann

Classifications

• G01N33/6842 Primary

  Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins · CPC title

• G01N2333/91205

  Phosphotransferases in general · CPC title

• C12Y207/11025

  Mitogen-activated protein kinase kinase kinase (2.7.11.25), i.e. MAPKKK or MAP3K · CPC title

• G01N33/573 Primary

  for enzymes or isoenzymes · CPC title

• C12N9/12

  transferring phosphorus containing groups, e.g. kinases (2.7) · CPC title